SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-13-008031
Filing Date
2013-02-19
Accepted
2013-02-19 14:38:50
Documents
1
Group Members
MARK NORDLICHTPLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLCPLATINUM MANAGEMENT (NY) LLCPLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P.PLATINUM PARTNERS VALUE ARBITRAGE FUND L.P.PLATINUM-MONTAUR LIFE SCIENCES LLC

Document Format Files

Seq Description Document Type Size
1 PLATINUM LONG TERM GROWTH VII, LLC SC 13G A NO 4 12-31-2012 (ECHO THERAPEUTICS I formsc13ga.htm SC 13G/A 163844
  Complete submission text file 0001140361-13-008031.txt   166043
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Subject) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52931 | Film No.: 13622877
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-271-7866
Platinum Long Term Growth VII, LLC (Filed by) CIK: 0001413041 (see all company filings)

IRS No.: 412203299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A